2021 Visionary: Q&A with Teresa K. Woodruff


Endocrine News talks with Teresa K. Woodruff, PhD, recipient of the 2021 Endocrine Society Gerald D. Aurbach Award for Outstanding Translational Research about what the award means to her and how she came to focus her life’s work on oncofertility, a phrase that she first coined in 2006.


Teresa K. Woodruff, PhD, is no stranger to the Endocrine Society. As past president and former editor-in-chief of Endocrinology, Woodruff’s dedication to the specialty is well-renowned. It should come as no surprise then that she has been recognized as the 2021 Laureate recipient of the Gerald D. Aurbach Award for Outstanding Translational Research — an award recognizing outstanding contributions to research that accelerate the transition of scientific discoveries into clinical applications.

Woodruff is provost at Michigan State University in East Lansing, Mich., and the founder and director of the Oncofertility Consortium. The Consortium is an international team comprised of oncologists, fertility specialists, social scientists, educators, and policy makers armed with the mission of translating Woodruff’s research to the clinical care of cancer survivors facing the struggles of infertility.

Endocrine News recently spoke with her to learn how the oncofertility sub-specialty became her purpose.

Endocrine News: The Laureate Award is named in honor of Dr. Gerald Aurbach, the Society’s 68th president and a renowned researcher and clinician. As a former president of the Society yourself, what did news of the recognition mean to you?

Woodruff: Dr. Aurbach was a renowned president of the Society and combined administrative and service excellence with his groundbreaking translational work. I am always struck by how often excellence in one is interoperable with the other, and Dr. Aurbach is a template.

EN: How did oncofertility become the pinpoint of your life’s work? That is, was there a defining moment early in your career that sparked the trajectory into the specialty?

Woodruff: I was the basic science director for the Northwestern Lurie Comprehensive Cancer Center and was alerted that a young boy was coming downtown from our children’s hospital to bank sperm. I thought that was terrific and asked, “how to we take care of the pediatric girls?” Realizing there was nothing we did for pediatric, adolescent, or young adult women led to the formation of this field of medicine.

The vision of the field of oncofertility is for all patients facing loss of fertility due to medical conditions and/or gonadotoxic therapies to have access to oncofertility options and services. 

EN: The website for your Oncofertility Consortium lists more than 140 partner facilities in the U.S. and dozens more abroad. What is the collective message you hope to send to women and couples across the globe facing the difficult challenges of conceiving after a cancer diagnosis?

Woodruff: The vision of the field of oncofertility is for all patients facing loss of fertility due to medical conditions and/or gonadotoxic therapies to have access to oncofertility options and services. The Oncofertility Consortium convened the field to enable the essential conversations necessary to drive oncofertility research, clinical practice, and patient options forward. We do this through shared values including collegiality, multi-disciplinary collaboration, inclusiveness, innovation, and altruism.  All of its values are ultimately driven by patient-centeredness.

Fauntleroy Shaw is a freelance writer based in Carmel, Ind. She is a regular contributor to Endocrine News.



You may also like

  • Brainstorming: Q&A with Michael W. Schwartz, MD

    Endocrine News talks to Michael W. Schwartz, MD, the 2022 Laureate recipient of the Roy O. Greep Award for Outstanding Research about his life and career in academic research that all started with a fascination with how the brain controls behavior. With his significant contributions in uncovering how our brain regulates energy balance and glucose…

  • Movers & Shakers: Lab Relocation During a Pandemic

    Moving is always stressful. Just imagine factoring in social distancing protocols, adhering to California’s earthquake safety standards, and pausing your research to get it done. Joy Y. Wu, MD, PhD, talks to Endocrine News about moving her research lab at Stanford University under less-than-ideal circumstances but she and her team got it done with a…

Find more in